Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(14 sites)
United States
UC San Diego Moores Cancer Center, La Jolla, California Sarah Cannon Research Institute at HealthONE, Denver, Colorado Yale Cancer Center, New Haven, Connecticut SCRI Florida Cancer Specialists - Sarasota, Sarasota, Florida Dana-Farber Cancer Institute, Boston, Massachusetts South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids, Michigan Washington University, St Louis, Missouri Cleveland Clinic, Cleveland, Ohio UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania University of Texas Southwestern Medical Center, Dallas, Texas MD Anderson Cancer Center, Houston, Texas South Texas Accelerated Research Therapeutics (START) San Antonio, San Antonio, Texas South Texas Accelerated Research Therapeutics (START) Mountain Region, West Valley City, Utah NEXT Virginia, Fairfax, Virginia